RAC1P7

Across TCGA pan-cancer cohorts, RAC1P7 RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated RAC1P7 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher RAC1P7 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RAC1P7 expression acts as an unfavorable survival marker, although some lineages such as ESCA show a favorable association.

STAD, KIRP, and LUSC are the cancer types where RAC1P7 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Tertile	II,III,IV	0.478	0.673	<.001	84	view →
KIRP	OS	Tertile	All	0.550	0.911	<.001	75	view →
LUSC	OS	Tertile	II,III,IV	0.414	0.752	.001	66	view →
MESO	OS	Tertile	IV	0.077	0.592	.019	45	view →
ESCA	OS	Quartile	III,IV	0.807	0.441	.002	36	view →
LGG	DFS	Tertile	All	0.671	0.836	.023	27	view →
SKCM	DFS	Tertile	All	0.195	0.760	.001	18	view →
CHOL	OS	Tertile	III,IV	0.275	0.886	.045	18	view →
PAAD	DFS	Tertile	All	0.188	0.475	.029	18	view →
LIHC	DFS	Tertile	All	0.038	0.553	<.001	18	view →
CESC	DFS	Tertile	All	0.089	0.546	.004	18	view →
COAD	DFS	Tertile	III,IV	0.168	0.616	.049	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

RAC1P7–STAD (DFS)

Open the STAD breakdown →